Bioteque (4107) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.075x

Based on the latest financial reports, Bioteque (4107) has a cash flow conversion efficiency ratio of 0.075x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$252.40 Million ≈ $7.95 Million USD) by net assets (NT$3.38 Billion ≈ $106.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 4107 market cap overview for the company's overall valuation and market capitalisation.

Bioteque - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Bioteque's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bioteque Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioteque ranked by their cash flow conversion efficiency. Explore Bioteque (4107) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Santhera Pharmaceuticals Holding AG SW:SANN	1.199x
Poya International Co Ltd TWO:5904	0.197x
Panora Gayrimenkul Yatirim Ortakligi AS IS:PAGYO	0.011x
Monogram Orthopaedics Inc. Common Stock NASDAQ:MGRM	-0.267x
Jena Acquisition Corporation II NYSE:JENA	-0.001x
BROOGE ENERGY DL-0001 F:3SF	N/A
Bank Of Princeton NASDAQ:BPRN	0.045x
CS Disco LLC NYSE:LAW	-0.094x

Annual Cash Flow Conversion Efficiency for Bioteque (2006–2025)

The table below shows the annual cash flow conversion efficiency of Bioteque from 2006 to 2025. View current stock price of Bioteque for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$3.61 Billion ≈ $113.65 Million	NT$664.20 Million ≈ $20.93 Million	0.184x	-9.82%
2024-12-31	NT$3.44 Billion ≈ $108.41 Million	NT$702.62 Million ≈ $22.14 Million	0.204x	-2.69%
2023-12-31	NT$3.19 Billion ≈ $100.51 Million	NT$669.40 Million ≈ $21.09 Million	0.210x	-1.30%
2022-12-31	NT$3.03 Billion ≈ $95.52 Million	NT$644.58 Million ≈ $20.31 Million	0.213x	+27.00%
2021-12-31	NT$2.80 Billion ≈ $88.32 Million	NT$469.25 Million ≈ $14.78 Million	0.167x	-29.71%
2020-12-31	NT$2.66 Billion ≈ $83.94 Million	NT$634.51 Million ≈ $19.99 Million	0.238x	-4.95%
2019-12-31	NT$2.49 Billion ≈ $78.39 Million	NT$623.41 Million ≈ $19.64 Million	0.251x	+25.93%
2018-12-31	NT$2.31 Billion ≈ $72.90 Million	NT$460.41 Million ≈ $14.51 Million	0.199x	+26.34%
2017-12-31	NT$2.14 Billion ≈ $67.32 Million	NT$336.51 Million ≈ $10.60 Million	0.157x	-14.05%
2016-12-31	NT$2.08 Billion ≈ $65.45 Million	NT$380.63 Million ≈ $11.99 Million	0.183x	-9.79%
2015-12-31	NT$1.90 Billion ≈ $59.79 Million	NT$385.43 Million ≈ $12.14 Million	0.203x	+3.65%
2014-12-31	NT$1.88 Billion ≈ $59.28 Million	NT$368.71 Million ≈ $11.62 Million	0.196x	+17.08%
2013-12-31	NT$1.62 Billion ≈ $50.91 Million	NT$270.44 Million ≈ $8.52 Million	0.167x	+17.11%
2012-12-31	NT$1.28 Billion ≈ $40.44 Million	NT$183.44 Million ≈ $5.78 Million	0.143x	+19.48%
2011-12-31	NT$1.24 Billion ≈ $39.10 Million	NT$148.43 Million ≈ $4.68 Million	0.120x	-19.79%
2010-12-31	NT$1.24 Billion ≈ $39.17 Million	NT$185.39 Million ≈ $5.84 Million	0.149x	+7.17%
2009-12-31	NT$1.25 Billion ≈ $39.47 Million	NT$174.32 Million ≈ $5.49 Million	0.139x	-40.46%
2008-12-31	NT$1.19 Billion ≈ $37.37 Million	NT$277.23 Million ≈ $8.73 Million	0.234x	+71.56%
2007-12-31	NT$1.17 Billion ≈ $36.95 Million	NT$159.77 Million ≈ $5.03 Million	0.136x	+36.92%
2006-12-31	NT$778.61 Million ≈ $24.53 Million	NT$77.47 Million ≈ $2.44 Million	0.099x	--

About Bioteque

TWO:4107 Taiwan Medical Instruments & Supplies

Market Cap

$243.43 Million

NT$7.73 Billion TWD

Market Cap Rank

#15862 Global

#720 in Taiwan

Share Price

NT$111.50

Change (1 day)

+0.45%

52-Week Range

NT$110.50 - NT$129.00

All Time High

NT$144.00